Meeder Asset Management’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$2.98K Buy
2021
Q2
Sell
2021
Q1
$6K Buy
2020
Q2
Sell
2020
Q1
$1K Hold
2019
Q4
$1K Buy